JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...

Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.